Why we should use long-acting injectable antipsychotics more frequently

Maia-de-Oliveira, João Paulo
Bressan, Rodrigo Affonseca
Elkis, Helio
Machado-de-Sousa, João Paulo
Hallak, Jaime Eduardo Cecilio

Open PDF

Open link

Publication date

September 2013

DOI

10.1590/1516-4446-2013-3503

Publisher

FapUNIFESP (SciELO)

Journal

Brazilian Journal of Psychiatry

Abstract

Universidade de São Paulo Faculdade de Medicina de Ribeirão Preto Department of Neuroscience and BehaviorConselho Nacional de Desenvolvimento Científico e Tecnológico National Science and Technology Institute for Translational MedicineUniversidade Federal do Rio Grande do Norte Department of Clinical MedicineUniversidade Federal de São Paulo (UNIFESP) Department of Psychiatry Interdisciplinary Laboratory of Clinical NeurosciencesUSP School of Medicine Department and Institute of PsychiatryUNIFESP, Department of Psychiatry Interdisciplinary Laboratory of Clinical NeurosciencesSciEL

Extracted data

We use cookies to provide a better user experience.

Data Protection

Why we should use long-acting injectable antipsychotics more frequently

Abstract

Extracted data

Why we should use long-acting injectable antipsychotics more frequently

Abstract

Extracted data

Related items

Related items